{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:00:19Z","timestamp":1791252019941,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T00:00:00Z","timestamp":1689465600000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000942","name":"Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000942","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.autrev.2022.103145","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T10:29:49Z","timestamp":1657880989000},"page":"103145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Psychiatric manifestations of autoimmune encephalitis"],"prefix":"10.1016","volume":"21","author":[{"given":"Hannah","family":"Ford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrew","family":"Swayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Velakoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashri","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastura","family":"Monif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103145_bb0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2022.103145_bb0010","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103145_bb0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0020","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.autrev.2022.103145_bb0025","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3201\/eid1509.081540","article-title":"Etiology of encephalitis in Australia, 1990-2007","volume":"15","author":"Huppatz","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.autrev.2022.103145_bb0030","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project","volume":"54","author":"Gable","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2022.103145_bb0045","first-page":"25","article-title":"Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken","year":"2017","journal-title":"Front Psych"},{"key":"10.1016\/j.autrev.2022.103145_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0055","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","article-title":"The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data","volume":"6","author":"Al-Diwani","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/acps.12941","article-title":"Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis","volume":"138","author":"Warren","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.autrev.2022.103145_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1012","article-title":"Prodromal headache in anti-NMDAR encephalitis: an epiphenomenon of NMDAR autoimmunity","volume":"8","author":"Tominaga","year":"2018","journal-title":"Brain Behav"},{"key":"10.1016\/j.autrev.2022.103145_bb0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.genhosppsych.2014.02.010","article-title":"Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions","volume":"36","author":"Kuppuswamy","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0085","article-title":"Neuropsychiatric phenotypes of anti-NMDAR encephalitis: a prospective study","volume":"1-9","author":"Espinola-Nadurille","year":"2022","journal-title":"Psychol Med"},{"key":"10.1016\/j.autrev.2022.103145_bb0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12888-017-1477-x","article-title":"Case report of anti-N-methyl-D-aspartate receptor encephalitis in a middle-aged woman with a long history of major depressive disorder","volume":"17","author":"Rong","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0095","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1177\/0883073812438099","article-title":"Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis mimicking a primary psychiatric disorder in an adolescent","volume":"27","author":"Lebon","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0100","article-title":"Case report: severe adolescent major depressive syndrome turns out to be an unusual case of anti-NMDA receptor encephalitis","volume":"12","author":"Moldavski","year":"2021","journal-title":"Front Psych"},{"key":"10.1016\/j.autrev.2022.103145_bb0105","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1176\/appi.ajp.2017.17030282","article-title":"Cycloid Psychosis","volume":"175","author":"El-Mallakh","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0110","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/ccr3.2522","article-title":"Considerations of psychotic symptomatology in anti-NMDA encephalitis: similarity to cycloid psychosis","volume":"7","author":"Gine Serven","year":"2019","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.autrev.2022.103145_bb0115","doi-asserted-by":"crossref","first-page":"e01980","DOI":"10.1002\/brb3.1980","article-title":"Cycloid psychosis as a psychiatric expression of anti-NMDAR encephalitis. A systematic review of case reports accomplished with the authors\u2019 cooperation","volume":"11","author":"Gine Serven","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.autrev.2022.103145_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S0033291700043336","article-title":"The course and outcome of cycloid psychosis","volume":"12","author":"Brockington","year":"1982","journal-title":"Psychol Med"},{"key":"10.1016\/j.autrev.2022.103145_bb0125","first-page":"89","article-title":"A rare case of anti-N-methyl-D-aspartate receptor encephalitis during pregnancy","volume":"128","author":"Chan","year":"2015","journal-title":"N Z Med J"},{"key":"10.1016\/j.autrev.2022.103145_bb0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/practneurol-2018-002042","article-title":"Anti-NMDAR encephalitis complicating pregnancy","volume":"19","author":"Kalam","year":"2019","journal-title":"Pract Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tjog.2017.04.009","article-title":"Anti-N-methyl\u2011d-aspartate receptor (NMDAR) encephalitis during pregnancy: clinical analysis of reported cases","volume":"56","author":"Shi","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2022.103145_bb0140","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archneurol.2010.133","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy","volume":"67","author":"Kumar","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0145","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1176\/appi.ajp.2015.14101332","article-title":"Autoimmune encephalitis in postpartum psychosis","volume":"172","author":"Bergink","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5144\/0256-4947.2012.421","article-title":"Anti-NMDA-receptor encephalitis presenting as postpartum psychosis in a young woman, treated with rituximab","volume":"32","author":"Shaaban","year":"2012","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.autrev.2022.103145_bb0155","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/jog.13262","article-title":"Anti-NMDA-receptor encephalitis during pregnancy: a case report and literature review","volume":"43","author":"Xiao","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.autrev.2022.103145_bb0160","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12888-017-1427-7","article-title":"The global prevalence of postpartum psychosis: a systematic review","volume":"17","author":"VanderKruik","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0165","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2169\/internalmedicine.56.7442","article-title":"Postpartum anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review","volume":"56","author":"Doden","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2022.103145_bb0175","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000668","article-title":"Pregnancy outcomes in anti-NMDA receptor encephalitis: case series","volume":"7","author":"Joubert","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2022.103145_bb0180","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0185","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2022.103145_bb0190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejpn.2017.08.004","article-title":"Limbic encephalitis with LGI1 antibodies in a 14-year-old boy","volume":"22","author":"Schimmel","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0195","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/1039856218771513","article-title":"LGI1 antibody encephalitis and psychosis","volume":"26","author":"Wang","year":"2018","journal-title":"Australas Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0200","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0205","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12883-018-1099-z","article-title":"Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study","volume":"18","author":"Li","year":"2018","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0210","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0215","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1080\/00207454.2019.1567507","article-title":"Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series","volume":"129","author":"Yang","year":"2019","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.autrev.2022.103145_bb0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2169\/internalmedicine.2963-19","article-title":"Anti-leucine-rich glioma Inactivated-1 encephalitis associated with essential Thrombocythemia","volume":"59","author":"Yuan","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2022.103145_bb0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2018.02.005","article-title":"Psychiatric symptoms delay the diagnosis of anti-LGI1 encephalitis","volume":"317","author":"Jang","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2022.103145_bb0230","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000051","article-title":"Leucine-rich glioma-inactivated protein 1 antibody encephalitis: a case report","volume":"1","author":"Mayasi","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2022.103145_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10060375","article-title":"Psychiatric manifestation of anti-LGI1 encephalitis","volume":"10","author":"Endres","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.autrev.2022.103145_bb0240","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.05.048","article-title":"Natural course of LGI1 encephalitis: 3-5 years of follow-up without immunotherapy","volume":"343","author":"Szots","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2022.103145_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217083","article-title":"LGI1 encephalitis: a disease of jerks and confusion","volume":"2016","author":"Dash","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2022.103145_bb0250","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1684\/epd.2020.1213","article-title":"Efficacy of rituximab on seizure control and cognitive symptoms in leucine-rich, glioma-inactivated 1 (LGI1) limbic encephalitis: a high-density electroencephalography case study","volume":"22","author":"Cheli","year":"2020","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.autrev.2022.103145_bb0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","volume":"74","author":"Finke","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0260","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.29271\/jcpsp.2021.09.1105","article-title":"Anti-leucine-rich-glioma-inactivated 1 limbic encephalitis: an Underrecognised disease","volume":"31","author":"Nabi","year":"2021","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.autrev.2022.103145_bb0265","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0275","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0280","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","article-title":"Systematic review of the clinical spectrum of CASPR2 antibody syndrome","volume":"267","author":"Boyko","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652864","article-title":"Clinical character of CASPR2 autoimmune encephalitis: a multiple center retrospective study","volume":"12","author":"Qin","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103145_bb0290","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with anti-Contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0295","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0004867418812687","article-title":"CASPR2 encephalitis presenting as post-partum psychosis","volume":"53","author":"Warren","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0300","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211073203","article-title":"Clinical characteristics, long-term functional outcomes and relapse of anti-LGI1\/Caspr2 encephalitis: a prospective cohort study in Western China","volume":"15","author":"Guo","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.autrev.2022.103145_bb0305","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12883-021-02520-1","article-title":"Clinical characteristics and prognosis of anti-alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0310","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients","volume":"84","author":"Hoftberger","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0315","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0320","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamaneurol.2015.1715","article-title":"Clinical Spectrum of encephalitis associated with antibodies against the alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor: case series and review of the literature","volume":"72","author":"Joubert","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0325","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001019","article-title":"Autoimmune global amnesia as manifestation of AMPAR encephalitis and Neuropathologic findings","volume":"8","author":"Ricken","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2022.103145_bb0330","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e3181d3e404","article-title":"The expanding clinical profile of anti-AMPA receptor encephalitis","volume":"74","author":"Graus","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0335","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/WCO.0000000000000814","article-title":"Anti-gamma-aminobutyric acid receptor type a encephalitis: a review","volume":"33","author":"Guo","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0340","article-title":"GABAA receptor autoimmunity: a multicenter experience","volume":"6","author":"O\u2019Connor","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2022.103145_bb0345","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0350","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1212\/WNL.0000000000010310","article-title":"GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis","volume":"95","author":"Maniscalco","year":"2020","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0355","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/practneurol-2019-002388","article-title":"Catatonia with GABAA receptor antibodies","volume":"20","author":"Samra","year":"2020","journal-title":"Pract Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0360","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"Hoftberger","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0365","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577471","article-title":"Long-term cognitive and neuropsychiatric outcomes of anti-GABABR encephalitis patients: a prospective study","volume":"351","author":"Lin","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2022.103145_bb0375","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00415-018-9132-0","article-title":"Isolated seizures are a common early feature of paraneoplastic anti-GABAB receptor encephalitis","volume":"266","author":"Maureille","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0380","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fneur.2020.00403","article-title":"Clinical characteristics of anti-GABA-B receptor encephalitis","volume":"11","author":"Zhu","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0385","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2014.02.011","article-title":"Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis","volume":"270","author":"Kim","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2022.103145_bb0390","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0395","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","author":"Tobin","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0400","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX antibody-associated encephalitis: Main syndrome and antibody effects","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0405","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","article-title":"Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons","volume":"85","author":"Piepgras","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0410","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/WNL.0000000000001183","article-title":"Neuropathologic features of anti-dipeptidyl-peptidase-like protein-6 antibody encephalitis","volume":"84","author":"Stokin","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0415","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0420","doi-asserted-by":"crossref","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","article-title":"Encephalitis with mGluR5 antibodies: symptoms and antibody effects","volume":"90","author":"Spatola","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0425","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1212\/WNL.0000000000002775","article-title":"Human neurexin-3alpha antibodies associate with encephalitis and alter synapse development","volume":"86","author":"Gresa-Arribas","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0430","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpsychires.2020.03.007","article-title":"Screening for anti-NMDAR encephalitis in psychiatry","volume":"125","author":"Warren","year":"2020","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.autrev.2022.103145_bb0435","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/oxfordjournals.schbul.a007040","article-title":"Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability","volume":"29","author":"Miller","year":"2003","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.autrev.2022.103145_bb0440","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s41380-021-01396-4","article-title":"Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany","volume":"27","author":"Endres","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0445","first-page":"13","article-title":"Synaptic and neuronal autoantibody-associated psychiatric syndromes: controversies and hypotheses","volume":"8","author":"Al-Diwani","year":"2017","journal-title":"Front Psych"},{"key":"10.1016\/j.autrev.2022.103145_bb0450","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S2215-0366(19)30190-7","article-title":"Catatonia and the immune system: a review","volume":"6","author":"Rogers","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0455","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1176\/appi.ajp.160.7.1233","article-title":"Catatonia in psychiatric classification: a home of its own","volume":"160","author":"Taylor","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0460","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41398-020-00989-x","article-title":"Cognitive impact of neuronal antibodies: encephalitis and beyond","volume":"10","author":"Gibson","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.autrev.2022.103145_bb0465","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001039","article-title":"Autoimmune encephalitis resembling dementia syndromes","volume":"8","author":"Bastiaansen","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2022.103145_bb0470","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00406-020-01113-2","article-title":"Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations","volume":"270","author":"Endres","year":"2020","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.autrev.2022.103145_bb0475","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WCO.0000000000000449","article-title":"Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis","volume":"30","author":"Spatola","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108571","article-title":"Electroclinical biomarkers of autoimmune encephalitis","volume":"128","author":"Wesselingh","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.autrev.2022.103145_bb0485","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/WNP.0000000000000654","article-title":"Continuous EEG findings in autoimmune encephalitis","volume":"38","author":"Moise","year":"2021","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.autrev.2022.103145_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2019.02.005","article-title":"EEG changes in patients on antipsychotic therapy: a systematic review","volume":"95","author":"Jackson","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.autrev.2022.103145_bb0495","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.wnp.0000229137.94384.fa","article-title":"Drug effects on EEG","volume":"23","author":"Blume","year":"2006","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.autrev.2022.103145_bb0500","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2022.103145_bb0505","doi-asserted-by":"crossref","first-page":"e1489","DOI":"10.1212\/WNL.0000000000200021","article-title":"Neurofilament light chain levels in anti-NMDAR encephalitis and primary psychiatric psychosis","volume":"98","author":"Guasp","year":"2022","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103145_bb0510","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2022.103145_bb0515","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: a systematic review","volume":"96","author":"Broadley","year":"2019","journal-title":"J Autoimmun"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722200115X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722200115X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:26:41Z","timestamp":1761600401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722200115X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":103,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S156899722200115X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103145","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychiatric manifestations of autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103145"}}